ege of Pharmacy, Uni ve rsi ty of Illin ois at C hi cago, C hi cago, Illin ois, U. S. A.
The o bj ectives of this study were to inves ti gate the absorp ti on of diazepam applied topi cally to th e hairless m o use in vivo and to determine the diffusio n of di azepam across isolated hairless mouse skin and human skin. [1 4CJDiazepam was readily absorbed after to pical administration to th e intact hairless m ouse, a total of 75.8% of the 14C-label applied being recovered in urine and feces .
Diazepam was found to diffuse across human and hairless mouse skin unch anged in experiments with twin-chambered diffu sion cells. The variation in diffusion rate or the flu x for both human and mou se tissues was grea ter among specimens than between duplicate or triplicate trials for a single specimen. Fluxes for mouse skin (stratum corneum, epidermis, and dermi s) w ere g reater than for human skin (s tratum corneum and epid ermi s): 0.35-0.61 p.g/cm 2 / h for mouse skin vs 0.24-0.42 p.g/cm 2 / h for human skin. The permea bility coeffi cients for mouse skin ranged from 1.4-2.4 x 1O -2 cm/h compared with 0. 8-] .4 x 1O -2 cm/h for human skin. Althou gh human stra tum corneum is almost twice th e thickness of that of the hairless mo use, the dif-D iaze pam (Valium, 7-chloro-l,3-dihydro-1-methyl-5-phenyl-2H-l,4-benzod iazepin-2-one) is a benzodiazepine used as an an xiolytic, sedative, hypnotic, and anticonvulsa nt agen t as well as a skeletal muscle relaxant [1 ,2) . Like many benzodi azepines , the biologic half-life of di azepam is long (20-50 h) , it is lipid soluble, and several metabolites possess pharmacologic ac tivity (3) . Anxiolytic effects can be anticipated at blood concentrations of300-400 ng/ ml diazepam (3) . T hese characteristi cs compli cate the use of this type of drug topically. For example, the long biologic halflife does no t assis t in effi cient delivery (4). However, di azepa m ca n be considered to be a good prototype for preliminary studies on the transdermal permea bility of benzodiazepine dru gs in general.
O bjectives of this study were to determine: (1) whether radi o labeled diazepam is absorbed in vivo folJowing topica l administration to the hairless mouse, (2) the in vitro diffusion rates of Manusc ript received April 15, 1986 ; accepted for publica tion September 23, 1986.
Reprint reques ts to: Ronald L. Koch, Ph. D., Department o f Ph arm,lceuti cs , Coll ege of Pharmacy, Uni versity of Illin o is at C hicago, C hicago, Illin ois 60612.
Abbrev iations: D: dermis I-IPLC: hi gh-performa nce liquid chro matography LS C: liqu id scintillation co untin g SCE: stratum co rneum and ep ider mis fusion coefficients for human skin were 3-12 times g rea ter (0.76-3.31 X 10 -6 cm 2 / h for human skin vs 0.12-0.27 X 10 -6 cm 2 / h for hairless mouse) beca use of a shorter lag time for diffu sion across hum an skin . These differences between th e diffusion coeffi cients and diffusio n rates (or permea bility coefficients) sugges t th at the presence of the der mis may present some barrier properties. [n vitro the dermis may require co mplete sa turation before the diazepam ca n be detected in the receivin g chamber.
[ 14 C ]Diazepam was not detected in the receiving chamber of th e Franz cell apparatus in experim ents with human skin . This indicated that the rate of diffusion was less than 0.09 p.g/ cm 2 /h. Since this diffu sion technique m o re closely resembles topical admini stration to hum ans , th ese results appear to indica te that achieving th erapeutic concentrations in humans may be difficult. In addition, the hairl ess mouse may not be a suitable m odel for predi cting percutaneous . Water for HPLC was filtered throu gh a Milli Q System (Waters Associates , Milford , Massachusetts). Female hairless mice, 6-9 weeks old , weighing 24-30 g, were purchased from Temple University (Philadelphia, Pennsylva nia). Twin-chambered diffusion ceUs [5) , designed with a magnetic stirring well in each chamber (2 ml per chamber) and a surface for diffusio n of 0.79 cm 2 , were made at the Research Resources Labora tory of the University of Illin ois (Chicago, Illinois). An 8-cell Franz diffusio n apparatus (5) with a 2.01-cm 2 surface for diffusion was purchased from the C rown Glass Co mpan y (Somerv ille, New J ersey).
In Vivo Mouse Experiments Diazepam. w as ad ministered to pically (1.0 /-Lg/ kg dose, 1 /-LC i in 0.05 ml 95% ethan ol) over a 2-cm 2 area on the back of the neck with a H amilton microsy ringe (Reno, N evada). The solvent was allowed to evapo rate and the area was left un covered for 24 h. Animals were housed in N alge free-standing meta bolism cages (Fisher Scientific) to aid in the collection of urine and feces. 
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VOL. 8 8, N O . 5 MAY 1987 radiolabd ass:lyed by li q ui d scintill ati o n co untin g (LSC, sec below). For co mp:lriso n , mi ce we n: also given thc sa me dose of diazcpa m i. p. (in 0.05 ml propy lcne g lyco l) :lnd their urin cs and feccs we re :l lso co llected and assayed for th e '~C-lab c l.
Hairless Mouse Skin After all owin g 2 weeks fo r "'C-labeled metabo li tes w ith a lo ng biolog ic half-life to be ex creted, th e mi ce used fo r the in vivo expe rim ents we re sacrifi ced b y cervica l dislocatio n . T he skin fr o m the bac k was re moved and tril11m ed o f fat a nd o the r cxtraneo us ti ss ues . The w ho le skin , co mprisin g stratum co rn eum and epidermis (SCE) ;lIld dermis (D), was used fo r t h e diffu sio n experim ents.
HUITlan Skin Sa lll p ics o f w ho le human cadaver sk in werc removed from the midl ine rcgio n of the chest less tlun 48 h after deat h . T he subcuta neo us fat was trimmed and the ti ss uc trea ted accordi ng to th e meth od s ofSwa rbrick et al1 71 bcfo re th e remova l o f thc SCE from the dermis. T he SCE ~/ as then d ricd in a desiccato r ll1 ain ta in ed at appro xim ately 25 % rcbtivc humidity for 2-3 days. T he dried S:l lll pleS we re w rapped in aluminum fo il and sto red in the refri ge rato r at 5°C and rehyd rated by imille rsin g the ti ss u e in water at roo m temperat ure for i h befo re usc 171.
Diffusion Experiments Using Tw in-Chambered Diffusion Cells Whole m ouse skin (SCE and D) o r hUl11 an skin (SCE) was pla ced between the two chambers of the twin-cham bercd cell s . Approx imately 50 J.L g of di aze pam (-0.23 J.LC i), disso lved in ethano l (0.05 1111), was added to the do no r (stratu m corn cum) side o f thc cell conta inin g 2 ml of sa lin e. Sa lin e 2 ml was added to t h e rcceiving chamber and th e cells we re in cubated in a 35°C water bath . Two 0.05-1111 sa mples we rc takcn fr o m the rcceivi ng cham.be r thro ug h the sa mplin g port at 0, 0.5, I, 2, 3, 4, 5, and 6 h . Each sa mple was rcplaced w ith an equa l vo lum c of sa line. Samp lcs we rc assaycd for the "' C _lab cl by a li quid scin till atio n co unte r (sce LS C below). The scnsiti vity of this method wi ll
Diffusion Experiments Using the Franz Cell Apparatus
App r ox im ately 50 J.L g of di aze pam (0. 1 J.LC i) , dissolve d in 0.05 ml et h ano l, was placed o n the stratum co rn eum sur face (-2 C1112) and t h c ethan o l allowcd to eva po rate. T he receivin g chal11ber was kept a t 35°C by a circulatin g watcr bath . Two O.05-1ll 1 sa l11ples of the sa lin e so lu tio n in the rcce ivin g chambcr werc ta kcn at 0, 0. 5, 1 , 2, 3, 4, 5, and 6 h thro ugh the sa mplin g side arm. Each sa mple was rcplaced by an eq ual vo lulTl c of sa l inc. Sa mpl cs we re assa ycd for th c "'C_label by LSC. T hc se nsiti vit y of thi s l11 ethod w ill detect :l diffusio n ratc o f 0.09 J.L g/cm 2 /h.
Analysis of Samples by HPLC Sa mples fr o m the do no r and recciv in g sidcs of th e twin-chambercd diffu sio n cclls we re storcd at -20°C until analyzcd. Fres hl y thawed sa mplcs (1-ml aliquo t s) were cx tracted usin g a C- 
vials and 0.3 ml of glac ial acetic acid was added followed by 10 ml of scin ti ll atio n cocktail. All sa m ples we re m eas ured for the 1·1 -l abe l w ith a Tri-Ca rb 4000 se ri es liquid scintillati o n counter (85-95'Yo cfficicncy) fro m Packard Instrument Co mpan y, In c.
(Dow ners G rove, Illino is).
Calculation of Diffusion Rates or Flux 0) Diffusio n ra tes o r flu x 0) we re determined from the slo pe of the diffusio n curves 171 and cx pressed as the amo unt o f drug passi ng across a squ are ce ntim cter of skin surface over tim e (J.Lg/cm 2 / h). T he pamea bility coeffi cicnts (P) were determined by dividing the o bse rv ed va lue fo r flu x by the initi al drug concentratio n in the do no r cell (25 J.Lg/c I11 3 ) . T his va lue ca nnot be de ri ved for ex periments with the Fran z cell beca use the do no r so lve nts are allowed to evaporate. A linea r regression program was used to determin e the eq uati o n o f the line for thc linear po rti o n of the diffusio n curve [9] . Fo llow in g the determin atio n of the la g time (tau, t) and skin thickness (h) the diffusio n coeffi cients (D) were calculated usin g D h 2 /6t [1 0 1·
RES ULTS
Absorption Across Hairless Mouse Skin In Vivo Follow in g topical admini stratio n of [ 2-'~C ]di azepa m , recovery of the I~C label in urine and feces after 3 days was 54.8 ± 1.5% and 21.0 ± 2.3% , res pectively. Total recovery of the label in urine and feces after 3 da ys was 75.8 ± 2.3% (Table I ). After i.p. adm inistratio n, the recovery of the '4C_Iabel in urine and feces was 40.3 ± 6.4% and 47.2 ± 3.6%, res pectively. T he relat ive bi oava ilabili ty of the '4C_Iabel applied to picall y co mpared w ith i. p. administration was g reater than 86%. T his indica tes that (Table II ) . Permeability coeffi cients were fo un d to ran ge from 1.4-2.4 X 10 -2 cm / h. Th e lag times ranged from 0.50-1 .1 4 h determined from thc x-interce pt va lues of regresssion lin es that bes t fitted the diffusion curves (Fig 1) . The diffusion coefficients ran gcd from 0. 12-0.27 X 10 -6 cm 2 / h and were fo und no t to be signifi cantly different for twi n-chambered cells co mpared to Franz diffu sion cells. Hi gh-perfo rm ance liquid chro m atog raph y analys is of the I.IC_ hble in the donor and receivin g chambe rs of the twin-chambe red diffusio n ccll yiclded a single radioactivc peak wit h a rete ntio n tim e of 6.0 min , identica l to di azepa m. A typi ca l HPLC chro1l1 atog ram of l" 'Cldiaze pam toget her with the radi oactive data fro m eluate sa 1l1ples analyzed by LSC is presented in Fig 2. Diffusion Across Human Skin In Vitro T he diffu sio n rate of "The applicatioll site of to pi cal administratio n was washed 3 times wi th I % Tween 80 using cotto n swabs . T he swabs were placed in liquid scintilbtio n vials. cocktai l was "dded, and the via ls counted . NA = no r applicable. ''Tw in-chambered (T C) ce lls have 3 O.79-cm' surface area for diffu sio n. Fran;; (f'j cells ha ve a 2.05-cm' surface arca for diffu sio n. 'Sec 11 31 for the thi ckness ofst"tul1l corn eum (0.<) X 10-) CI1l) .
cSkill ti ssue was no t th e S;lII1 C as # 2 lIsed for twin-chal1lbered cdls due to in~lIffi ci c nt amo llnt o f skin . JNA = N ot appli ca ble w ith Franz diffusion cells.
The la g times ranged from 0.13-0.64 h . and the diffusion coeffi cient ranged from 0.76-3.31 X 10 -6 cm 2 / h (Fig 3) . Only diazepa m was found following HPLC and LS C analysis of th e contents of the receiving chamber. The diffusion rates in experiments with th e Franz cell could not be determined for the amounts of 14C-label detected were below the sensitivity of our assay (0.09 J-Lgi cm 2 I h).
DISCUSS IO N
[2-14 C 1Diazepam was read ily absorbed throug h the intact sk in of the hairl ess mouse. The relative bioavailability of topi cally applied [ 14 C ldiazepam compared with i. p. administration was greater than 86%. These results suggest that most of the drug applied to the skin was absorbed over the 24-h treatment period . However, we w ere un able to determin e from these ex perim ents whe ther the absorbed materia l was diazepam o r its metabolites. Diaze pam was found to diffuse un chan ged ac ross both human SCE and whole mouse sk in. The diffusion rate of dia zepam across hairless mouse skin in vitro was found to be simi lar for the twin- ge neral, the d iffusion rates across mouse skin for both diffusion systems were g reater than across human skin (range 0.24-0.42
J-Lg/c m
2 / h) usi n g twin-cham bered cells. The whole mouse skin (-0.44mm) used in these experiments was approximately 7 times thicker than hum an sk in (SCE -0.06 mm , [13] ).
Since the stratum corneum is considered the m ajor barrier to diffusion, on ly the thickness of this layer was used in calculating the diffusion coefficients [14] . However, the calculated diffu sion coefficients for hum an skin were 3-12 times greater than for mouse skin (0.76-3.31 X 10 - mo u se (-9 ,um ) and the hum an skin appeared to have a shorter lag p e ri od than whole mouse skin ; bo th factors greatl y influence this calculati on [1 0, 13] . The longe r lag tim e fo r whole mouse skin indi cates that the presence of th e dermis m ay present some barrie r pro perties. R e p ea ted trials of a specimen of bo th human and mouse tissues varie d less than the individual specimens (Ta bles II, Ill). Beca use of the individual differences, data wre not pooled but their range of values are repo rted.
One unexpected findin g w as the lack of di ffu sion o r a diffusion ra te less th an the sensitivity of o ur assay (0.09 ,ug/cm 2 / h) across human skin using Franz diffusion cells. This is probably due to the thickness of the human stratum corn eum and poss ibly to the ph ysi cal state of the applied diazepam . Exposure to the atmosphere in the Franz cell will have rem oved so lvent and the drug is like ly to be precipitated on the surface. In the twin-chambered cells the drug remains in solsution . Sin ce the Franz cell more closely resembles th e topical application of drugs to humans [5, 15] , it w ould appea r to indicate that topical application in humans may prove to be diffi cult . Accelerants or penetrati on enhancers may be re quired in o rd er to kee p di azepam in solution to increase abso rptio n and reach effi cacious plas m a con centrations [3, 16] . In addition , the hairless mouse m ay no t be a suitable model fo r predi c ting the percutaneous absorption of diazepam in humans. Z.4 ""~ In future experiments w e plan to stud y the effe cts of the dermis on the diffusion rates and coeffi cients of diazepam with hairless mo use skin. The effects of accelerants on di azepam diffusio n will be inves ti gated to improve the flu x so as to approach therapeutic plasma concentrations .
We wish to tlJar,k Dr. Geoffrey W . ). Lee fo r vaillable disCllssiom in th e preparatioll of this IIIQ/IIlScript.
